Skip navigation

These are not the Best of times for the pharmaceutical industry. More regulations, increased federal scrutiny, pricing pressures, and a tarnished public image all cloud the present — and future — of the industry. But along with these challenges come opportunities for meeting professionals — opportunities to not only elevate their status within their companies, but also to help the industry as a whole, said Michael W. Young, senior director, global oncology strategy, Eisai Inc., La Jolla,

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.